IMMUCELL CORPICCC

Neutral

ASignal's systematic analysis rates ICCC as Neutral.

Reflects the latest available analysis · analyzed Oct 25, 2026

The case on ICCC

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Positive MACD crossover with expanding histogram indicates strengthening momentum
  • Price above 20-day and 50-day SMAs suggests uptrend
  • Strong operating margin of 26.93% indicates pricing power and cost control
  • Debt-to-equity ratio of 0.40x reflects healthy capital structure
  • Current ratio of 4.75x and quick ratio of 2.65x signal strong liquidity
VS
Bear case
  • Extremely high P/E of 146.43x and negative forward P/E raise valuation concerns
  • Low net profit margin of 2.57% despite high operating margin
  • Return on equity of 2.57% indicates weak shareholder returns
  • Only one news source (Yahoo) and no Reddit mentions suggest limited market attention
  • PEG ratio not available due to negative forward P/E, limiting growth-adjusted valuation
Subscriber-only

See the full verdict on ICCC

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes ICCC

Most investors never get a second opinion, let alone several. ASignal runs ICCC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

IMMUCELL CORP (ICCC) Stock Analysis - ASignal rates it Neutral